MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'daniel carlat'. Sat, 03 Sep 2011 02:20:51 +0100 http://www.medworm.com/index.php?rid=3776378&cid=t_125614_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Flife-without-a-mental-disorder-is-it-possible%2F2010.07.21 There’s a noteworthy column in Psychiatric Times, “Normality Is an Endangered Species: Psychiatric Fads and Overdiagnosis,” by Allen Frances, M.D. He was chair of the task force that worked on the Diagnostic & Statistical Manual — DSM-IV — one edition of the “bible of psychiatry.” He is professor emeritus of psychiatry at Duke University School of Medicine. There’s a lot of common ground between what Dr. Frances writes and what Dr. Daniel Carlat (the subject of an earlier blog posting) writes about. Dr. Frances is concerned about the directions that might be taken in the authoring of DSM-V, now underway. Excerpts: “Fads in psychiatric diagnosis come and go and have been with us as long as there has been psychiatry. The fads meet a d... Better Health blogs http://www.medworm.com/rss/comments.php?id=3776378 Wed, 21 Jul 2010 23:00:01 +0100 3776378 http://www.medworm.com/index.php?rid=3635678&cid=t_125614_83_f&fid=34856&url=http%3A%2F%2Finsidesurgery.com%2F2010%2F06%2Fpsychiatrists-drs-daniel-carlat-mark-townsend-discuss-psychiatric-effects-bp-oil-spill%2F Psychiatrists Dr. Daniel Carlat and Louisiana State University’s Dr. Mark Townsend discuss the psychiatric and post-traumatic stress disorder (PTSD) ramifications of the BP oil spill on Louisiana and other Gulf Coast residents. (Source: Inside Surgery) Inside Surgery blogs http://www.medworm.com/rss/comments.php?id=3635678 Sun, 06 Jun 2010 18:31:10 +0100 3635678 http://www.medworm.com/index.php?rid=3599770&cid=t_125614_167_f&fid=38576&url=http%3A%2F%2Fwww.drbriffa.com%2Fblog%2F2010%2F05%2F26%2Fpsychiatrist-blows-the-lid-on-the-psychiatric-profession%2F While I am fan of certain aspects of orthodox medicine, I think overall it’s less effective and more hazardous than we generally imagine. As I wrote recently here, there is some thought that less medicine can result in improved outcomes. There is certainly some evidence that less can be more, where conventional medical care is [...] (Source: Dr John Biffa's Blog) Dr John Biffa's Blog blogs http://www.medworm.com/rss/comments.php?id=3599770 Wed, 26 May 2010 16:25:39 +0100 3599770 http://www.medworm.com/index.php?rid=1645912&cid=t_125614_109_f&fid=34750&url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2008%2F07%2F22%2Finterview-with-psychiatrist-daniel-carlat-md%2F This report on medical education was about two years in the making and they also recommended that continuing medical education no longer be funded by the pharmaceutical industry, basically saying that the marketing aims of drug companies have become overly intertwined with continuing medical education. These physician groups were both saying that have lost control of the content of their accredited medical education, and that we need to take that control back. I’m not talking about promotional talks here—I’m talking about accredited, Category One CME, which is the credit doctors need in order to maintain their medical licenses in most states. So this type of education is really is a big deal, and has implications for the wellbeing of out patients. Aside from these two reports othe... World of Psychology blogs http://www.medworm.com/rss/comments.php?id=1645912 Tue, 22 Jul 2008 11:00:35 +0100 1645912 http://www.medworm.com/index.php?rid=1051231&cid=t_125614_109_f&fid=34800&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FClinicalPsychologyAndPsychiatryACloserLook%2F%7E3%2F190750785%2Feffexor-marketing-and-dr-drug-rep.html Great job by Dr. Daniel Carlat. Read his piece in the New York Times Magazine regarding his stint as Dr. Drug Rep, when he stumped for Wyeth's antidepressant Effexor for a cool $30k in one year. Not bad work if you can get it. It is a fascinating account of a common industry practice -- train doctors to give speeches to other doctors in which certain treatment is pushed hard. Overplay efficacy and downplay negative effects. Drug companies state, with a straight face, that this is "educating" physicians -- buying them fancy dinners and having one of their colleagues read company-produced marketing slides on their product.Carlat's blog is also a great source of information. (Source: Clinical Psychology and Psychiatry: A Closer Look) Clinical Psychology and Psychiatry: A Closer Look blogs http://www.medworm.com/rss/comments.php?id=1051231 Mon, 26 Nov 2007 15:10:00 +0100 1051231 http://www.medworm.com/index.php?rid=1040246&cid=t_125614_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F187821903%2F Can the pharmaceutical industry be trusted to fund compulsory education without introducing bias? We all know the issue is academics, drugmakers and, of course, docs. And the Senate recently released a critical report. However, Nature reports today that new preliminary data suggests industry-sponsored courses skew training material in favor of commercial interests. Jatinder Takhar, a psychiatrist who heads the CME office at the University of Western Ontario in Canada, grew interested in the issue after attending a CME presentation on antipsychotics that she’d audited and approved for her university. But she noticed a problem. “The slides had been changed,” she tells Nature. “The data were slanted and the presentation was more promotional and less educational” than it ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1040246 Tue, 20 Nov 2007 17:44:53 +0100 1040246 http://www.medworm.com/index.php?rid=927861&cid=t_125614_109_f&fid=34800&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FClinicalPsychologyAndPsychiatryACloserLook%2F%7E3%2F165235167%2Fshove-your-gifts-where-sun-dont-shine.html There is great rant posted by Dr. Daniel Carlat, that ends with We don't need gifts from drug reps, nor do we need the biased "education" they provide during their visits. Let's stop pretending that gifts are anything other than influence-peddling.Read his rant and, while on his site, check out many other excellent posts. It is no secret that I am a big fan of his work. We need many more psychiatrists who are capable of seeing through the marketing blitzkrieg that has come to dominate modern psychiatry. (Source: Clinical Psychology and Psychiatry: A Closer Look) Clinical Psychology and Psychiatry: A Closer Look blogs http://www.medworm.com/rss/comments.php?id=927861 Thu, 04 Oct 2007 14:34:00 +0100 927861 http://www.medworm.com/index.php?rid=840784&cid=t_125614_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F152173312%2F That’s how C. Lindsay DeVane described his own ACCME-accredited article, which was published last May in the journal CNS Spectrums. DeVane, a psychiatry professor and vice chair of research in the clinical neuroscience division at the Medical University of South Carolina, offered this blunt assessment in an e-mail he wrote to Dan Carlat, an industry gadfly who blogs about CME issues. The reason for their exchange was Carlat’s recent fascination with the story behind the article, which was accredited and produced by i3 CME, a medical education company owned by Ingenix, and which was funded by Bristol-Myers Squibb. The article, which was about antidepressant drug-drug interactions, emerged from what was originally a televised roundtable but was adapted by medical writers to form ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=840784 Tue, 04 Sep 2007 19:22:37 +0100 840784 http://www.medworm.com/index.php?rid=799231&cid=t_125614_109_f&fid=34800&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FClinicalPsychologyAndPsychiatryACloserLook%2F%7E3%2F144166368%2Fwhen-to-say-sorry.html In a recent post, Daniel Carlat apologized to Charles Nemeroff for nicknaming him "Bling Bling" in a prior post. So what? Who cares? Well, I think we need to take a look at what behavior requires an apology and what does not. I'm not saying I have the answers, but I think the issue is quite important.Let's look at some documented issues regarding Nemeroff:ARISE-RD 1: Nemeroff was an author on a study (called ARISE-RD) examining the use of risperidone as an antidepressant. The study results did not demonstrate that the drug worked, especially after the authors issued a correction indicating that one of the findings in the published version of the study was incorrect (oops -- sorry that we mentioned that the drug worked; we screwed up -- it really did not work).ARISE-RD 2: The study results ... Clinical Psychology and Psychiatry: A Closer Look blogs http://www.medworm.com/rss/comments.php?id=799231 Tue, 14 Aug 2007 23:25:00 +0100 799231 http://www.medworm.com/index.php?rid=682684&cid=t_125614_109_f&fid=34800&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FClinicalPsychologyAndPsychiatryACloserLook%2F%7E3%2F125977037%2Fbreath-of-fresh-air.html I am quite happy to introduce my readers to Daniel Carlat’s new blog, The Carlat Psychiatry Report. Dr. Carlat, as I’ve reported earlier, writes about psychiatry in a newsletter that provides continuing education for psychiatrists. He also had a recent piece in the New York Times decrying the influence of industry in continuing medical education. I’m a big fan of his work. There are few blogs that report critically on the sneaky marketing of the drug industry in psychiatry, and I strongly suspect that Carlat’s site is going to be a welcome addition to the blogosphere. I expect his writings will help detail the farce that medical education has become, where doctors are exposed to thinly veiled drug advertising which passes for education in order to keep doctors apprised of the “l... Clinical Psychology and Psychiatry: A Closer Look blogs http://www.medworm.com/rss/comments.php?id=682684 Tue, 19 Jun 2007 03:21:00 +0100 682684